Suppr超能文献

在固定矫治器治疗期间使用氟化物预防早期龋齿(脱矿白色病变)。

Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace treatment.

作者信息

Benson Philip E, Parkin Nicola, Dyer Fiona, Millett Declan T, Furness Susan, Germain Peter

机构信息

Academic Unit of Oral Health and Development, School of Clinical Dentistry, University of Sheffield, Claremont Crescent, Sheffield, UK, S10 2TA.

出版信息

Cochrane Database Syst Rev. 2013 Dec 12(12):CD003809. doi: 10.1002/14651858.CD003809.pub3.

Abstract

BACKGROUND

Demineralised white lesions (DWLs) can appear on teeth during fixed brace treatment because of early decay around the brackets that attach the braces to the teeth. Fluoride is effective in reducing decay in susceptible individuals in the general population. Individuals receiving orthodontic treatment may be prescribed various forms of fluoride treatment. This review compares the effects of various forms of fluoride used during orthodontic treatment on the development of DWLs. This is an update of a Cochrane review first published in 2004.

OBJECTIVES

The primary objective of this review was to evaluate the effects of fluoride in reducing the incidence of DWLs on the teeth during orthodontic treatment.The secondary objectives were to examine the effectiveness of different modes of fluoride delivery in reducing the incidence of DWLs, as well as the size of lesions. Participant-assessed outcomes, such as perception of DWLs, and oral health-related quality of life data were to be included, as would reports of adverse effects.

SEARCH METHODS

We searched the Cochrane Oral Health Group's Trials Register (to 31 January 2013); the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 12); MEDLINE via OVID (1946 to 31 January 2013); and EMBASE via OVID (1980 to 31 January 2013).

SELECTION CRITERIA

We included trials if they met the following criteria: (1) parallel-group randomised clinical trials comparing the use of a fluoride-containing product versus placebo, no treatment or a different type of fluoride treatment, in which (2) the outcome of enamel demineralisation was assessed at the start and at the end of orthodontic treatment.

DATA COLLECTION AND ANALYSIS

At least two review authors independently, in duplicate, conducted risk of bias assessments and extracted data. Authors of trials were contacted to obtain missing data or to ask for clarification of aspects of trial methodology. The Cochrane Collaboration's statistical guidelines were followed.

MAIN RESULTS

For the 2013 update of this review, three changes were made to the protocol regarding inclusion criteria. Fourteen studies included in the previous version of the review were excluded from this update for the following reasons: five previously included studies were quasi-randomised, a further five were split-mouth studies, three measured outcomes on extracted teeth only and in one, the same fluoride intervention was used in each intervention group of the study.Three studies and 458 participants were included in this updated review. One study was assessed at low risk of bias for all domains, in one study the risk of bias was unclear and in the remaining study, the risk of bias was high.One placebo-controlled study of fluoride varnish applied every six weeks (253 participants, low risk of bias), provided moderate-quality evidence of an almost 70% reduction in DWLs (risk ratio (RR) 0.31, 95% confidence interval (CI) 0.21 to 0.44, P value < 0.001). This finding is considered to provide moderate-quality evidence for this intervention because it has not yet been replicated by further studies in orthodontic participants.One study compared two different formulations of fluoride toothpaste and mouthrinse prescribed for participants undergoing orthodontic treatment (97 participants, unclear risk of bias) and found no difference between an amine fluoride and stannous fluoride toothpaste/mouthrinse combination and a sodium fluoride toothpaste/mouthrinse combination for the outcomes of white spot index, visible plaque index and gingival bleeding index.One small study (37 participants) compared the use of an intraoral fluoride-releasing glass bead device attached to the brace versus a daily fluoride mouthrinse. The study was assessed at high risk of bias because a substantial number of participants were lost to follow-up, and compliance with use of the mouthrinse was not measured.Neither secondary outcomes of this review nor adverse effects of interventions were reported in any of the included studies.

AUTHORS' CONCLUSIONS: This review found some moderate evidence that fluoride varnish applied every six weeks at the time of orthodontic review during treatment is effective, but this finding is based on a single study. Further adequately powered, double-blind, randomised controlled trials are required to determine the best means of preventing DWLs in patients undergoing orthodontic treatment and the most accurate means of assessing compliance with treatment and possible adverse effects. Future studies should follow up participants beyond the end of orthodontic treatment to determine the effect of DWLs on participant satisfaction with treatment.

摘要

背景

在固定矫治器治疗期间,由于粘贴矫治器的托槽周围早期龋坏,牙齿上可能会出现脱矿白色病变(DWL)。氟化物对降低普通人群中易感个体的龋坏有效。接受正畸治疗的个体可能会被开具各种形式的氟化物治疗。本综述比较了正畸治疗期间使用的各种形式氟化物对DWL发生的影响。这是2004年首次发表的Cochrane综述的更新版。

目的

本综述的主要目的是评估氟化物在正畸治疗期间降低牙齿上DWL发生率的效果。次要目的是研究不同氟化物给药方式在降低DWL发生率以及病变大小方面的有效性。还将纳入参与者评估的结果,如对DWL的认知,以及与口腔健康相关的生活质量数据,以及不良反应报告。

检索方法

我们检索了Cochrane口腔健康组试验注册库(至2013年1月31日);Cochrane对照试验中央注册库(CENTRAL)(《Cochrane图书馆》2012年第12期);通过OVID检索MEDLINE(1946年至2013年1月31日);以及通过OVID检索EMBASE(1980年至2013年1月31日)。

选择标准

如果试验符合以下标准,我们将其纳入:(1)平行组随机临床试验,比较含氟产品与安慰剂、无治疗或不同类型氟化物治疗的使用情况,其中(2)在正畸治疗开始时和结束时评估釉质脱矿的结果。

数据收集与分析

至少两名综述作者独立地、重复地进行偏倚风险评估并提取数据。联系试验作者以获取缺失数据或要求澄清试验方法的各个方面。遵循Cochrane协作网的统计指南。

主要结果

对于本综述2013年的更新版,关于纳入标准,方案有三处更改。本更新版排除了上一版综述中纳入的14项研究,原因如下:之前纳入的5项研究为准随机研究,另外5项为自身对照研究,3项仅在拔除的牙齿上测量结果,还有1项研究中,每个干预组使用的是相同的氟化物干预措施。本更新版综述纳入了3项研究和458名参与者。一项研究在所有领域的偏倚风险评估为低,一项研究的偏倚风险不明确,其余一项研究的偏倚风险高。一项每六周应用一次氟化物 varnish的安慰剂对照研究(253名参与者,低偏倚风险),提供了中等质量的证据,表明DWL减少了近70%(风险比(RR)0.31,95%置信区间(CI)0.21至0.44,P值<0.001)。这一发现被认为为本干预措施提供了中等质量的证据,因为正畸参与者的进一步研究尚未重复这一结果。一项研究比较了为正畸治疗参与者开具的两种不同配方的含氟牙膏和漱口水(97名参与者,偏倚风险不明确),发现胺氟化物和氟化亚锡牙膏/漱口水组合与氟化钠牙膏/漱口水组合在白斑指数、可见菌斑指数和牙龈出血指数结果方面没有差异。一项小型研究(37名参与者)比较了固定在矫治器上的口腔内释氟玻璃珠装置与每日氟化物漱口水的使用情况。该研究的偏倚风险评估为高,因为大量参与者失访,且未测量漱口水的使用依从性。纳入的任何研究均未报告本综述的次要结果或干预措施的不良反应。

作者结论

本综述发现一些中等证据表明,在治疗期间正畸复查时每六周应用一次氟化物 varnish是有效的,但这一发现仅基于一项研究。需要进一步进行有足够样本量的、双盲、随机对照试验,以确定预防正畸治疗患者DWL的最佳方法以及评估治疗依从性和可能不良反应的最准确方法。未来的研究应在正畸治疗结束后对参与者进行随访,以确定DWL对参与者治疗满意度的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验